UB Research Provides Biochemical Explanation For Obesity

April 07, 1997

NEW ORLEANS -- Research at the University at Buffalo is the first to provide a biochemical explanation for obesity that could help pave the way for development of treatments for the condition.

Mulchand S. Patel, Ph.D., professor and chair of the UB Department of Biochemistry, reported here today (Monday, April 7) that research with rat pups has shown that different tissues exhibit specific responses to hyperinsulinemia, the overproduction of insulin that occurs in obesity.

Unlike previous animal models in which both conditions occur simultaneously, the UB model is the first to demonstrate that chronic hyperinsulinemia precedes obesity.

Working with rat pups born to mothers who were hyperinsulinemic and obese, the UB researchers have measured the effect of chronic hyperinsulinemia on key enzymes in the insulin-signaling pathway.

"Our results show that in the presence of an overproduction of insulin, obesity develops because while the functional activity of the insulin-signal transduction pathway is decreased in liver and muscle tissue, its activity is increased in fatty tissue," said Patel. "This information provides a biochemical basis for the development of obesity and may make it possible one day to develop specific interventions for obesity."

Patel reported the results at Experimental Biology '97, the annual meeting of the Federation of American Societies for Experimental Biology. He conducted the work with Malathi Srinivasan, Ph.D., and Satyaprasad Vadlamudi, Ph.D., postdoctoral associates in biochemistry at UB.

Patel said the findings suggests the rat pups have an early metabolic setpoint, which programs them to overproduce insulin early in life and become obese later on.

Normally, insulin is produced by the pancreas in varying levels, depending on the amount of glucose in the blood.

But while in utero, the pancreatic cells of these offspring somehow are targeted to overproduce insulin by hormonal or environmental influences from the mothers, who are hyperinsulinemic and obese, said Patel.

"The pancreatic cells in the pups respond to the hyperinsulinemia in the mothers early on, and later in adult life, the body responds to the offspring's hyperinsulinemia," he continued.

"It's a big mystery as to how this happens because these second-generation animals experience no dietary modification," Patel said. He noted that the rat pups' only risk factor is that they were born to hyperinsulinemic mothers.

"In our study, second generation rats express hyperinsulinemia early in the post-weaning period, as their mothers did," stated Patel. "In spite of the fact that they were not eating a high-carbohydrate diet, the pups' metabolic setpoint may have a similar pattern to the mothers'."

The UB researchers now are trying to pinpoint exactly how early in their lives the rats begin to exhibit hyperinsulinemia and whether or not they are born with it.

This work builds on previous research by Patel that showed that diet-induced metabolic adaptations in the early stage of first-generation rats were transmitted to the second generation.
-end-


University at Buffalo

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.